Mast Immunosystems Inc., Hitachi Chemical Co. Ltd. deal

Hitachi will acquire the remaining 75 percent of Mast it does not already own in a cash-merger deal that would value Mast at $40 million. Mast develops and sells in vitro diagnostics. Hitachi has been...